![Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis | Clinics Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis | Clinics](https://static.elsevier.es/multimedia/18075932/000000750000000C/v1_202211290815/S1807593222004768/v1_202211290815/en/main.assets/gr2.jpeg)
Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis | Clinics
Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus | PLOS Neglected Tropical Diseases
![Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6 | Translational Psychiatry Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6 | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Ftp.2015.142/MediaObjects/41398_2015_Article_BFtp2015142_Fig1_HTML.jpg)
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6 | Translational Psychiatry
![Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models](https://www.spandidos-publications.com/article_images/mmr/7/5/MMR-07-05-1470-g00.jpg)
Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models
![Interleukin-6 and Related Proteins as Biomarkers in Systemic Sclerosis - Christopher P. Denton, Voon H. Ong, 2017 Interleukin-6 and Related Proteins as Biomarkers in Systemic Sclerosis - Christopher P. Denton, Voon H. Ong, 2017](https://journals.sagepub.com/cms/10.5301/jsrd.5000266/asset/images/large/10.5301_jsrd.5000266-fig1.jpeg)
Interleukin-6 and Related Proteins as Biomarkers in Systemic Sclerosis - Christopher P. Denton, Voon H. Ong, 2017
![Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases | Arthritis Research & Therapy | Full Text Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases | Arthritis Research & Therapy | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13075-015-0887-8/MediaObjects/13075_2015_887_Fig2_HTML.gif)
Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases | Arthritis Research & Therapy | Full Text
![Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level | Journal of Proteome Research Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.0c00365/asset/images/medium/pr0c00365_0003.gif)
Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level | Journal of Proteome Research
![JCM | Free Full-Text | On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases JCM | Free Full-Text | On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases](https://pub.mdpi-res.com/jcm/jcm-09-00800/article_deploy/html/images/jcm-09-00800-g001.png?1585796806)
JCM | Free Full-Text | On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
![Frontiers | IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive Frontiers | IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive](https://www.frontiersin.org/files/Articles/604866/fphar-11-604866-HTML/image_m/fphar-11-604866-g001.jpg)
Frontiers | IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive
![Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients | Journal of Interferon & Cytokine Research Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients | Journal of Interferon & Cytokine Research](https://www.liebertpub.com/cms/10.1089/jir.2018.0169/asset/images/medium/figure1.gif)
Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients | Journal of Interferon & Cytokine Research
![Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage | Scientific Reports Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-79586-3/MediaObjects/41598_2020_79586_Fig1_HTML.png)
Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage | Scientific Reports
![Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/462f0f6f-a326-4055-8ad3-8cb256c67314/gr1_lrg.jpg)
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
![Mechanisms and pathologic significances in increase in serum interleukin-6 ( IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease - ScienceDirect Mechanisms and pathologic significances in increase in serum interleukin-6 ( IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120518466-gr4.jpg)
Mechanisms and pathologic significances in increase in serum interleukin-6 ( IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease - ScienceDirect
![Serum interleukin-6 (IL-6) from lipopolysaccharide (LPS)-treated rats.... | Download Scientific Diagram Serum interleukin-6 (IL-6) from lipopolysaccharide (LPS)-treated rats.... | Download Scientific Diagram](https://www.researchgate.net/publication/23761836/figure/fig4/AS:310164386271243@1450960360249/Serum-interleukin-6-IL-6-from-lipopolysaccharide-LPS-treated-rats-IL-6-levels-were.png)
Serum interleukin-6 (IL-6) from lipopolysaccharide (LPS)-treated rats.... | Download Scientific Diagram
![Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases | International Journal of Colorectal Disease Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases | International Journal of Colorectal Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00384-018-3069-8/MediaObjects/384_2018_3069_Fig4_HTML.gif)
Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases | International Journal of Colorectal Disease
![Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy - IOS Press Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy - IOS Press](https://content.iospress.com/media/jnd/2022/9-1/jnd-9-1-jnd210711/jnd-9-jnd210711-g003.jpg)
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy - IOS Press
![Serum IL-6 levels in wild-type and MK2/mice. Serum IL-6 was analyzed... | Download Scientific Diagram Serum IL-6 levels in wild-type and MK2/mice. Serum IL-6 was analyzed... | Download Scientific Diagram](https://www.researchgate.net/publication/44629358/figure/fig3/AS:601736796438533@1520476640062/Serum-IL-6-levels-in-wild-type-and-MK2-mice-Serum-IL-6-was-analyzed-with-ELISA-technique.png)
Serum IL-6 levels in wild-type and MK2/mice. Serum IL-6 was analyzed... | Download Scientific Diagram
![Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors](https://immunenetwork.org/ArticleImage/0078IN/in-20-e27-g001-l.jpg)
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
![Cancers | Free Full-Text | High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma Cancers | Free Full-Text | High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma](https://www.mdpi.com/cancers/cancers-14-05985/article_deploy/html/images/cancers-14-05985-g002.png)